$Ra Pharmaceuticals(RARX)$ EU pharma quite active in H2 so far on M&As

July: Boehringer Ingelheim / Amal Tx, Zambon / Breath Tx
Aug: Bayer / BlueRock Tx
Sept: Lundbeck / Alder Biopharma, SOBI / Dova Pharma
Oct: UCB / Ra Pharma

延续了最近欧洲药企来抄底的主题